New Clinical Prediction Model May Personalize Statin Muscle-Risk Counseling

A large retrospective cohort study published in Lancet Digital Health from England suggests a new clinical prediction model to help clinicians discuss serious muscle risks more clearly with patients considering or already taking statins. The model focuses on clinically consequential events like rhabdomyolysis, reinforcing that such serious disorders are uncommon for most statin-eligible adults.